A high burden of SDOH is linked to worse respiratory symptoms and reduced exercise capacity after SARS-CoV-2 infection.
Distinct lipid signatures identified in blood plasma and exhaled breath can differentiate IPF from fibrotic hypersensitivity pneumonitis.